secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2026-05-28T20:05:17+00:00
Accession:  0001193125-26-245181
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Standard BioTools approves severance plans for CEO, CFO, and CBO through 2028
-----------------------------------------------------------------------------

- 2026 Severance Plan for CFO Alex Kim and CBO Sean Mackay: outside COC, 12 months salary, prorated bonus, COBRA subsidy, equity acceleration if terminated by Aug 27, 2026.
- During COC: non-CEOs receive 150% of salary plus target bonus lump sum, 18 months COBRA, and full equity vesting.
- CEO Michael Egholm covered under 2023 Severance Plan: outside COC, 200% salary over 24 months, 12 months COBRA, outplacement.
- During COC: CEO gets 250% of salary plus bonus lump sum, 30 months COBRA, and full equity vesting.
- 2026 Severance Plan supersedes the 2024 plan; both plans expire August 4, 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/0001193125-26-245181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/lab-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-245181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer